
Sign up to save your podcasts
Or
Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine.
Find our substack and all promotional links here:
4.9
231231 ratings
Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine.
Find our substack and all promotional links here:
1,200 Listeners
335 Listeners
36 Listeners
54 Listeners
512 Listeners
261 Listeners
1,603 Listeners
375 Listeners
56 Listeners
49 Listeners
194 Listeners
170 Listeners
20 Listeners
98 Listeners
23 Listeners